Hear from two thought leaders who share their passion for health economics, their thoughts on non-traditional models, and how they predict drugs will be costed in the future.

COVID-19 has revealed a pandemic of another kind: existing health inequities between population groups. We explore the role and responsibility of medical affairs teams in addressing imbalances and forging a fairer and more inclusive health landscape for the future

What are the obstacles in the way of rolling out precision medicine and how can medical affairs professionals overcome them to fast-track adoption for patients?

What role can medical affairs professionals play in filling this knowledge gap as they communicate the importance of sexual health?

Cyber-attacks have become a mounting threat to the pharmaceutical industry over the past year, putting COVID-19 research data as well as supply and distribution chains at risk. We explore what can pharma learn from more experienced industries as they try to mitigate hacking

Dr Nick West, Chief Medical Officer, Abbott Vascular, shares with GOLD his hopes for the future of personalised care, enhancing patient centricity worldwide and the upskilling potential of virtual reality.

What value can Digital Opinion Leaders (DOLs) bring to medical affairs?

The gender pay gap is far from solved, how companies can address the imbalance head-on?